Cambridge Investment Research Advisors’s Everus Construction Group ECG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
6,463
-2,397
-27% -$351K ﹤0.01% 2252
2026
Q1
$1.05M Buy
8,860
+1,345
+18% +$139K ﹤0.01% 2137
2025
Q4
$643K Buy
7,515
+4,394
+141% +$393K ﹤0.01% 2489
2025
Q3
$268K Sell
3,121
-554
-15% -$41.2K ﹤0.01% 3209
2025
Q2
$233K Sell
3,675
-3,254
-47% -$165K ﹤0.01% 3204
2025
Q1
$257K Sell
6,929
-3,618
-34% -$195K ﹤0.01% 3001
2024
Q4
$693K Buy
+10,547
New +$664K ﹤0.01% 2165

Other funds holding ECG

Cambridge Investment Research Advisors's ECG Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Everus Construction Group (ECG) stake by 27% in Q2 2026, selling an estimated $351K and leaving 6,463 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2252.

Cambridge Investment Research Advisors first reported a position in ECG in Q4 2024 and has held it in 7 quarters since. 536 funds tracked by Wall St. Rank hold ECG as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,463 shares of Everus Construction Group worth $1.07M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,397 Everus Construction Group shares in Q2 2026, an estimated $351K.
  • Everus Construction Group made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2252 holding.
  • Cambridge Investment Research Advisors first reported a position in Everus Construction Group in Q4 2024 and has held it in 7 quarters since.
  • 536 funds tracked by Wall St. Rank held Everus Construction Group as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.